The reprogrammed cells resemble mature β-cells in that that are capable of producing significant amounts of insulin (33.5±7.3 pmol/μg protein) when compared to human islets (226.7±9.5 pmol/μg protein), are glucose responsive, phenotypically stable, and are capable of rescuing diabetes in an in vivo setting. The gene discussed is INS; the disease is diabetes mellitus.